167 related articles for article (PubMed ID: 16288880)
1. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling.
Ishida J; Yamamoto H; Kido Y; Kamijo K; Murano K; Miyake H; Ohkubo M; Kinoshita T; Warizaya M; Iwashita A; Mihara K; Matsuoka N; Hattori K
Bioorg Med Chem; 2006 Mar; 14(5):1378-90. PubMed ID: 16288880
[TBL] [Abstract][Full Text] [Related]
2. Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors.
Iwashita A; Hattori K; Yamamoto H; Ishida J; Kido Y; Kamijo K; Murano K; Miyake H; Kinoshita T; Warizaya M; Ohkubo M; Matsuoka N; Mutoh S
FEBS Lett; 2005 Feb; 579(6):1389-93. PubMed ID: 15733846
[TBL] [Abstract][Full Text] [Related]
3. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors.
Yao H; Ji M; Zhu Z; Zhou J; Cao R; Chen X; Xu B
Bioorg Med Chem; 2015 Feb; 23(4):681-93. PubMed ID: 25614115
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel PARP-1 inhibitors by structure-based virtual screening.
Hannigan K; Kulkarni SS; Bdzhola VG; Golub AG; Yarmoluk SM; Talele TT
Bioorg Med Chem Lett; 2013 Nov; 23(21):5790-4. PubMed ID: 24074844
[TBL] [Abstract][Full Text] [Related]
6. Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure-activity relationship analysis.
Costantino G; Macchiarulo A; Camaioni E; Pellicciari R
J Med Chem; 2001 Nov; 44(23):3786-94. PubMed ID: 11689065
[TBL] [Abstract][Full Text] [Related]
7. Rational approaches to discovery of orally active and brain-penetrable quinazolinone inhibitors of poly(ADP-ribose)polymerase.
Hattori K; Kido Y; Yamamoto H; Ishida J; Kamijo K; Murano K; Ohkubo M; Kinoshita T; Iwashita A; Mihara K; Yamazaki S; Matsuoka N; Teramura Y; Miyake H
J Med Chem; 2004 Aug; 47(17):4151-4. PubMed ID: 15293985
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of novel poly(ADP-ribose) polymerase-1 inhibitors.
Tao M; Park CH; Bihovsky R; Wells GJ; Husten J; Ator MA; Hudkins RL
Bioorg Med Chem Lett; 2006 Feb; 16(4):938-42. PubMed ID: 16290935
[TBL] [Abstract][Full Text] [Related]
9. Phthalazinones 2: Optimisation and synthesis of novel potent inhibitors of poly(ADP-ribose)polymerase.
Cockcroft XL; Dillon KJ; Dixon L; Drzewiecki J; Kerrigan F; Loh VM; Martin NM; Menear KA; Smith GC
Bioorg Med Chem Lett; 2006 Feb; 16(4):1040-4. PubMed ID: 16290932
[TBL] [Abstract][Full Text] [Related]
10. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.
Orvieto F; Branca D; Giomini C; Jones P; Koch U; Ontoria JM; Palumbi MC; Rowley M; Toniatti C; Muraglia E
Bioorg Med Chem Lett; 2009 Aug; 19(15):4196-200. PubMed ID: 19541484
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of a novel poly(ADP-ribose) polymerase-1 inhibitor, 2-[3-[4-(4-chlorophenyl)-1-piperazinyl] propyl]-4(3H)-quinazolinone (FR255595), in an in vitro model of cell death and in mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Iwashita A; Yamazaki S; Mihara K; Hattori K; Yamamoto H; Ishida J; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Jun; 309(3):1067-78. PubMed ID: 14985416
[TBL] [Abstract][Full Text] [Related]
12. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase.
Menear KA; Adcock C; Alonso FC; Blackburn K; Copsey L; Drzewiecki J; Fundo A; Le Gall A; Gomez S; Javaid H; Lence CF; Martin NM; Mydlowski C; Smith GC
Bioorg Med Chem Lett; 2008 Jul; 18(14):3942-5. PubMed ID: 18579376
[TBL] [Abstract][Full Text] [Related]
13. Discovery of quinazoline-2,4(1H,3H)-dione derivatives as novel PARP-1/2 inhibitors: design, synthesis and their antitumor activity.
Zhou J; Ji M; Yao H; Cao R; Zhao H; Wang X; Chen X; Xu B
Org Biomol Chem; 2018 May; 16(17):3189-3202. PubMed ID: 29648554
[TBL] [Abstract][Full Text] [Related]
14. On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives.
Pellicciari R; Camaioni E; Costantino G; Formentini L; Sabbatini P; Venturoni F; Eren G; Bellocchi D; Chiarugi A; Moroni F
ChemMedChem; 2008 Jun; 3(6):914-23. PubMed ID: 18409175
[TBL] [Abstract][Full Text] [Related]
15. PARP inhibitors: polypharmacology versus selective inhibition.
Ekblad T; Camaioni E; Schüler H; Macchiarulo A
FEBS J; 2013 Aug; 280(15):3563-75. PubMed ID: 23601167
[TBL] [Abstract][Full Text] [Related]
16. In silico investigation of PARP-1 catalytic domains in holo and apo states for the design of high-affinity PARP-1 inhibitors.
Salmas RE; Unlu A; Yurtsever M; Noskov SY; Durdagi S
J Enzyme Inhib Med Chem; 2016; 31(1):112-20. PubMed ID: 26083304
[TBL] [Abstract][Full Text] [Related]
17. A novel class of substituted spiro [quinazoline-2,1'-cyclohexane] derivatives as effective PPAR-1 inhibitors: molecular modeling, synthesis, cytotoxic and enzyme assay evaluation.
Amin KM; Anwar MM; Syam YM; Khedr MA; Kamel MM; Kassem EM
Acta Pol Pharm; 2013; 70(4):687-708. PubMed ID: 23923393
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, cytotoxic evaluation and molecular docking study of novel quinazoline derivatives as PARP-1 inhibitors.
Amin KM; Anwar MM; Kamel MM; Kassem EM; Syam YM; Elseginy SA
Acta Pol Pharm; 2013; 70(5):833-49. PubMed ID: 24147361
[TBL] [Abstract][Full Text] [Related]
19. Free energy calculation provides insight into the action mechanism of selective PARP-1 inhibitor.
Cao R
J Mol Model; 2016 Apr; 22(4):74. PubMed ID: 26969680
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the catalytic fragment of murine poly(ADP-ribose) polymerase-2.
Oliver AW; Amé JC; Roe SM; Good V; de Murcia G; Pearl LH
Nucleic Acids Res; 2004; 32(2):456-64. PubMed ID: 14739238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
